Crofoot Carmen MD Skowhegan, ME - 04976

Crofoot Carmen MD is categorized under Business Services (Unclassified) in Skowhegan, ME and active since 2012.

Crofoot Carmen MD was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.

If you are seeking more information, feel free to contact Carmen Crofoot at the company’s single location by writing to 46 Fairview Avenue, Skowhegan, Maine ME 04976 or by phoning (207) 474-3697. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Crofoot Carmen MD
Contact Person: Carmen Crofoot
Address: 46 Fairview Avenue, Skowhegan, Maine 04976
Phone Number: (207) 474-3697
Website Address: redingtonorthopedicsurgery.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Business Services (Unclassified)
SIC Code: 7389
NAICS Code: 561499
Share This Business:

Crofoot Carmen MD was started in 2012 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Carmen Crofoot for inquiries that concern Crofoot Carmen MD by calling the company number (207) 474-3697, as your correspondence is most welcome. Additionally, the physical location of the single location of Crofoot Carmen MD can be found at the coordinates 44.75338,-69.70898 as well as the street address 46 Fairview Avenue in Skowhegan, Maine 04976.

For its online presence, you may visit Crofoot Carmen MD’s website at redingtonorthopedicsurgery.com and engage with its social media outlets through on Twitter and on Facebook.